249
Participants
Start Date
February 8, 2022
Primary Completion Date
December 21, 2022
Study Completion Date
December 21, 2022
Pneumovax 23
At +14 days from enrollment in the trial, participants will receive a vaccine administered via intramuscular route only.
Typhim VI
At +14 days from enrollment in the trial, participants will receive a vaccine administered via intramuscular route only.
Saline
At +14 days from enrollment in the trial, participants will receive a vaccine administered via intramuscular route only.
Texas A&M University - CTRAL, College Station
Collaborators (1)
Philips Healthcare
INDUSTRY
US Department of Defense - Defense Threat Reduction Agency
UNKNOWN
Texas A&M University
OTHER